Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Siewert Type II Adenocarcinoma of Esophagogastric Junction”

16 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 16 of 16 results

Not applicableLooking for participantsNCT05356520
What this trial is testing

Comparison of Different Operations for Siewert Type II Adenocarcinoma of Esophagogastric Junction

Who this might be right for
Siewert Type II Adenocarcinoma of Esophagogastric Junction
Xijing Hospital of Digestive Diseases 212
Not applicableUnknownNCT04151524
What this trial is testing

Classification of Adenocarcinoma of the Esophagogastric Junction

Who this might be right for
Oesophagus CancerBarrett EsophagusSiewert Type I Adenocarcinoma of Esophagogastric Junction+2 more
St. James's Hospital, Ireland 1,658
Not applicableStudy completedNCT05419349
What this trial is testing

Novel Staging Schemes for Siewert Type II Esophagogastric Junction Adenocarcinoma: A Real-World Data Cohort Study From SEER Database

Who this might be right for
Adenocarcinoma of the Esophagogastric Junction
Fujian Medical University Union Hospital 1,819
Not applicableStudy completedNCT03416101
What this trial is testing

Siewert Type II Esophageal Adenocarcinoma: Relationship Between Histology and Survival

Who this might be right for
Siewert Type II Adenocarcinoma of Esophagogastric Junction
University of Bologna 154
Testing effectiveness (Phase 2)Study completedNCT01504256
What this trial is testing

Catumaxomab for Treatment of Peritoneal Carcinomatosis in Patients With Gastric Adenocarcinomas

Who this might be right for
Gastric Adenocarcinoma With Peritoneal CarcinomatosisSiewert Type II Adenocarcinoma of Esophagogastric Junction With Peritoneal CarcinomatosisSiewert Type III Adenocarcinoma of Esophagogastric Junction With Peritoneal Carcinomatosis
AIO-Studien-gGmbH 42
Not applicableLooking for participantsNCT07441785
What this trial is testing

Immediate and Functional Results of Different Types of Reconstructions After Proximal Gastrectomy For Gastric and Esophagogastric Junction Cancer

Who this might be right for
Gastric Cancer (GC)Siewert Type III Adenocarcinoma of Esophagogastric JunctionSiewert Type II Adenocarcinoma of Esophagogastric Junction
P. Herzen Moscow Oncology Research Institute 300
Testing effectiveness (Phase 2)Study completedNCT02559687
What this trial is testing

Study of Pembrolizumab (MK-3475) in Previously-Treated Participants With Advanced Carcinoma of the Esophagus or Esophagogastric Junction (MK-3475-180/KEYNOTE-180)

Who this might be right for
Esophageal CarcinomaEsophagogastric Junction Carcinoma
Merck Sharp & Dohme LLC 121
Not applicableStudy completedNCT06347757
What this trial is testing

A 3-Arm Study Comparing the Efficacy of Anti-Reflux Reconstruction Protocols After Laparoscopic Proximal Gastrectomy

Who this might be right for
Anti-Reflux Alimentary ReconstructionLaparoscopic Proximal GastrectomySiewert Type II/III Adenocarcinoma of the Esophagogastric Junction
Northern Jiangsu People's Hospital 180
Not applicableUnknownNCT02313688
What this trial is testing

Length of the Proximal Resection Margin for Siewert-II/Siewert-III Tumors

Who this might be right for
Stomach NeoplasmsSiewert Type II Adenocarcinoma of Esophagogastric JunctionRecurrence+1 more
West China Hospital 320
Not applicableLooking for participantsNCT04443478
What this trial is testing

Laparoscopic Versus Open Lower Mediastinal Lymphadenectomy for Esophagogastric Junction Cancer

Who this might be right for
Gastric Cancer
Peking University 1,036
Testing effectiveness (Phase 2)Looking for participantsNCT06044311
What this trial is testing

Oral TGF-beta Receptor I Inhibitor Vactosertib in SOC Chemoradiotherapy for Esophageal Adenocarcinoma

Who this might be right for
Adenocarcinoma EsophagusLocally Advanced AdenocarcinomaSiewert Type I Adenocarcinoma of Esophagogastric Junction+1 more
Sakti Chakrabarti 25
Not applicableUnknownNCT04423354
What this trial is testing

A Prospective Clinical Study of Transthoracic Single-hole Assisted Laparoscopic Radical Gastrectomy for Siewert Ⅱ AEG

Who this might be right for
Esophagogastric Junction AdenocarcinomaSiewert Type II Adenocarcinoma of Esophagogastric Junction
Guangdong Provincial Hospital of Traditional Chinese Medicine 94
Not applicableLooking for participantsNCT06644352
What this trial is testing

Right Versus Left Thoracic Surgical Approaches for Siewert II Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Siewert Type II Adenocarcinoma of Esophagogastric Junction
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 236
Testing effectiveness (Phase 2)Study completedNCT04034251
What this trial is testing

Intraperitoneal and Intravenous Paclitaxel Chemotherapy With Oral Capecitabine for Gastric Adenocarcinoma With Peritoneal Carcinomatosis

Who this might be right for
Gastric AdenocarcinomaGastric CancerEsophagogastric Junction+1 more
National Cancer Institute (NCI) 12
Testing effectiveness (Phase 2)Study completedNCT03092518
What this trial is testing

Heated Intraperitoneal Chemotherapy and Gastrectomy for Gastric Cancer With Positive Peritoneal Cytology

Who this might be right for
Gastric AdenocarcinomaEsophagogastric JunctionGastric Cancer
National Cancer Institute (NCI) 27
Not applicableUnknownNCT02741778
What this trial is testing

Minimally Invasive Sweet Esophagectomy for Patients With Siewert Type II Adenocarcinoma of the Esophagogastric Junction

Who this might be right for
Adenocarcinoma
Anhui Provincial Hospital 120